| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
10,541,233 | 7,857,179 | 5,798,096 | 3,682,049 | 5,122,173 |
| Cost of Revenue
|
-6,218,565 | -4,300,706 | -3,264,561 | -2,317,376 | -2,800,140 |
|
Gross Profit
|
4,322,668 | 3,556,473 | 2,533,535 | 1,364,673 | 2,322,033 |
| Selling, General and Administrative Expenses
|
-1,321,877 | -1,076,191 | -835,528 | -570,883 | -708,180 |
|
Research and Development Expenses
|
-521,337 | -416,122 | -347,159 | -231,882 | -254,358 |
|
Operating Income/Expenses
|
-1,843,214 | -1,492,313 | -1,182,687 | -802,765 | -962,538 |
|
Total Operating Profit/Loss
|
2,479,454 | 2,064,160 | 1,350,848 | 561,908 | 1,359,495 |
| Total Net Finance Income/Expense
|
44,054 | 43,845 | 8,566 | 10,617 | 6,902 |
| Irregular Income/Expenses
|
4,420 | 5,435 | 17,295 | -5,148 | -17,167 |
|
Other Income/Expense, Non-Operating
|
224,457 | -52,232 | 57,873 | -6,383 | 28,357 |
|
Non-Operating Income/Expenses, Total
|
272,931 | -2,952 | 83,734 | -914 | 18,092 |
|
Pretax Income
|
2,752,385 | 2,061,208 | 1,434,582 | 560,994 | 1,377,587 |
|
Provision for Income Tax
|
-526,509 | -388,336 | -248,745 | -96,956 | -277,355 |
|
Net Income from Continuing Operations
|
2,225,876 | 1,672,872 | 1,185,837 | 464,038 | 1,100,232 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
2,225,876 | 1,672,872 | 1,185,837 | 464,038 | 1,100,232 |
|
Net Income after Non-Controlling/Minority Interests
|
2,225,876 | 1,672,872 | 1,185,837 | 464,038 | 1,100,232 |
|
Net Income Available to Common Stockholders
|
2,225,876 | 1,672,872 | 1,185,837 | 464,038 | 1,100,232 |
|
Diluted Net Income Available to Common Stockholders
|
2,225,876 | 1,672,872 | 1,185,837 | 464,038 | 1,100,232 |
| Basic EPS
|
62.20 | 46.93 | 34.31 | 13.52 | 32.22 |
| Diluted EPS
|
61.52 | 46.54 | 33.61 | 13.35 | 31.73 |
|
Basic Weighted Average Shares Outstanding
|
35,768.62 | 35,646.11 | 34,562.43 | 34,322.34 | 34,147.49 |
|
Diluted Weighted Average Shares Outstanding
|
36,100.99 | 35,944.82 | 35,282.27 | 34,759.40 | 34,674.82 |
|
EBIT
|
2,708,331 | 2,017,363 | 1,426,016 | 550,377 | 1,370,685 |
|
EBITDA
|
2,982,753 | 2,275,438 | 1,662,760 | 677,619 | 1,492,932 |
|
Normalized EBITDA
|
3,029,890 | 2,345,062 | 1,730,377 | 778,364 | 1,531,528 |
|
Normalized Income
|
2,263,996.07 | 1,729,378.70 | 1,241,729.75 | 547,371.34 | 1,131,057.31 |
|
Total Unusual Items
|
47,137 | 69,624 | 67,617 | 100,745 | 38,596 |
|
Total Unusual Items Excluding Goodwill
|
47,137 | 69,624 | 67,617 | 100,745 | 38,596 |
|
Tax Effect of Unusual Items
|
9,016.93 | 13,117.30 | 11,724.25 | 17,411.66 | 7,770.69 |
|
Tax Rate, Calculated
|
0.19 | 0.19 | 0.17 | 0.17 | 0.20 |
12/31/2022 - 11/19/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade